Literature DB >> 8598762

Dysglycaemia and risk of cardiovascular disease.

H C Gerstein1, S Yusuf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8598762     DOI: 10.1016/s0140-6736(96)91420-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  23 in total

Review 1.  Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria.

Authors:  N J Wareham; S J Griffin
Journal:  BMJ       Date:  2001-04-21

2.  Prediction of cardiovascular risk. Program is not suitable for diabetic patients.

Authors:  A Zambanini; M R Smith; M D Feher
Journal:  BMJ       Date:  1999-05-22

3.  The DREAM trial and the prospect of diabetes prevention.

Authors:  Samy I McFarlane; Tanja Rundek; John Nicasio; Mrunalini Deshmukh; James R Sowers
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

4.  Very tight glucose control: May be high risk, low benefit.

Authors:  John S Yudkin
Journal:  BMJ       Date:  2008-03-29

Review 5.  Novel metabolic biomarkers of cardiovascular disease.

Authors:  Majken K Jensen; Monica L Bertoia; Leah E Cahill; Isha Agarwal; Eric B Rimm; Kenneth J Mukamal
Journal:  Nat Rev Endocrinol       Date:  2014-09-02       Impact factor: 43.330

6.  Haemoglobin A1c levels and subsequent cardiovascular disease in persons without diabetes: a meta-analysis of prospective cohorts.

Authors:  R Santos-Oliveira; C Purdy; M Pereira da Silva; A M dos Anjos Carneiro-Leão; M Machado; T R Einarson
Journal:  Diabetologia       Date:  2011-02-22       Impact factor: 10.122

Review 7.  Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus.

Authors:  A Evans; A J Krentz
Journal:  Drug Saf       Date:  1999-07       Impact factor: 5.606

8.  [ADA criteria undervalues the impact of diabetes in a high-risk Spanish population].

Authors:  F Martín Luján; B Costa Pinel; A Donado-Mazarrón Romero; T Basora Gallisà; J Basora Gallisà; J L Piñol Moreso
Journal:  Aten Primaria       Date:  2000-11-15       Impact factor: 1.137

9.  Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission.

Authors:  J Sala; R Masiá; F-J González de Molina; J M Fernández-Real; M Gil; D Bosch; W Ricart; M Sentí; J Marrugat
Journal:  J Epidemiol Community Health       Date:  2002-09       Impact factor: 3.710

10.  Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load.

Authors:  Lauren K Walsh; Robert M Restaino; Martha Neuringer; Camila Manrique; Jaume Padilla
Journal:  Clin Sci (Lond)       Date:  2016-08-08       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.